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ABSTRACT: We present a simple approach to calculate the kinetic properties of lipid membrane crossing processes from 
biased molecular dynamics simulations. We demonstrate that by using biased simulations, one can obtain highly accurate 
kinetic information with significantly reduced computational time with respect to unbiased simulations. We describe how to 
conveniently calculate the transition rates to enter, cross and exit the membrane in terms of mean first passage times. To 
obtain free energy barriers and relaxation times from biased simulations only, we constructed Markov models using the 
Dynamic Histogram Analysis Method (DHAM). The permeability coefficients that are calculated from the relaxation times 
are found to correlate highly with experimentally evaluated values. We show that more generally, certain calculated kinetic 
properties linked to the crossing of the membrane layer (e.g., barrier height and barrier crossing rates) are good indicators 
of ordering drugs by permeability. Extending the analysis to a 2D Markov model provides a physical description of the mem-
brane crossing mechanism.  
 
Figure 1.  Representation of the system used in the molecular dynamics simulations: a drug molecule (in brown at center of image) 
interacts with and passes through a lipid membrane which is surrounded by water.  
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I. INTRODUCTION 
For a drug to be effective, it has not only to bind strongly 
to its target, but it is also required to have good ADME 
(Absorption, Distribution, Metabolism, Excretion) pro-
file1. An important factor for the absorption and the dis-
tribution is the drug’s ability to cross the cell membrane 
to reach its target2-4. This has become particularly im-
portant for drugs that act in the central nervous system, 
and have to cross the blood brain barrier.1 This property 
is traditionally estimated by the lipophilicity of the drug. 
However, taking into account only the lipophilicity of the 
molecule does not allow to fully understand the mecha-
nism of membrane permeation (Fig. 1) and for this rea-
son subsequent, more refined models take into account 
additional physical parameters, such as depth-dependent 
partitioning and the resistance coefficient of the mem-
brane. For a fully quantitative description, it has become 
fundamental to predict the kinetic behaviour of drugs 
addressing membrane interaction and permeation.1, 5-8  
Studies related to the transport of small ligands crossing 
various phospholipid membranes are the subject of in-
creased interest in recent years5, 9-13. There are also sig-
nificant challenges to investigating this behaviour exper-
imentally. Eyer et al.14 proposed a liposomal fluorescence 
assay method by which the permeation of weak basic 
drug-like solutes across the lipid membrane can be de-
termined. However, details of membrane crossing mech-
anisms at an atomistic level are still missing experimen-
tally14.  
Figure 2. Chemical structure of the seven drugs analyzed by 
Eyer et al.14 
Thanks to the dramatic recent development of computer 
technology , molecular dynamics (MD) simulations are 
now capable of reaching biologically significant time-
scales and are becoming widely used in the pharmaceuti-
cal industry8, 15-25. In tandem with the improvement in 
simulation hardware and software, an important role has 
been played by the construction of mathematical models 
which allow the vast volumes of MD data to be processed 
in a statistically optimal manner. Markov state models 
(MSMs) have emerged as a useful tool for analyzing and 
understanding the results of these simulations. In fact, 
MSMs allow for the convenient combination of multiple 
MD trajectories into a single kinetic network model from 
which experimental observables and kinetic rates can be 
computed.6, 13, 26-28 
Using experimentally obtained permeabilities by Eyer et 
al.14 across a lipid membrane for seven structurally unre-
lated drugs (Fig. 2), Dickson et al.29 recently demonstrat-
ed that accurate results  for the permeability rates can be 
obtained by running long unbiased MD simulations29. By 
using an MSM formalism, kinetic rates of the key steps in 
membrane crossing can then be estimated. However, very 
large computational resources are required for a suffi-
ciently converged set of unbiased simulation trajectories 
to be analyzed by MSMs. With the use of enhanced sam-
pling biasing procedures, such as umbrella sampling 
(US), this computational time can be significantly re-
duced. 
The construction of MSMs from biased simulation data 
has not been traditionally possible. Biased simulations 
require the potential energy function of the system of 
interest to be modified such that the system is for exam-
ple harmonically restrained to a given region of the ener-
gy landscape. This is advantageous as it allows sampling 
of regions which might otherwise not be adequately vis-
ited during the simulation time. However, the kinetic be-
haviour observed is no longer representative of the true 
system and as such this needs to be accounted for when 
constructing the MSM. A recently derived unbiasing 
method, the Dynamic Histogram Analysis Meth-
od,(DHAM), by Rosta and Hummer30 uses a maximum 
likelihood estimate of the MSM transition probabilities 
given the observed transition counts during each biased 
trajectory and is found to often produce more accurate 
results than those of the more commonly used weighted 
histogram analysis method (WHAM)31. This unbiasing 
method is the first to use only biased US simulation data 
to obtain kinetic information directly by constructing the 
unbiased MSM. 
Here we determined the free energy profiles and kinetic 
rates of crossing a lipid membrane for the seven drugs in 
Fig. 2 by using US biased simulations. All experimental 
kinetic permeation data used for comparison for these 
seven drug molecules was previously obtained by Eyer et 
al14. Using this kinetic information, we aim to order the 
drugs according to their permeability coefficients (log 
Perm values). We analyzed US simulation data to calcu-
late kinetic rates for the entry into the membrane, flip-
ping, and exit from the membrane, and compared it with 
that obtained from long unbiased simulations. All MD 
simulation data (unbiased and US biased) was previously 
obtained by Dickson et al29. Here, we  re-analyzed the US 
biased data to obtain molecular kinetic rates for the 
membrane permeation using DHAM30. We found an excel-
lent agreement between the kinetic properties of the 
drugs from US biased simulations compared with those 
from the combined biased and unbiased MD simulations, 
which are also in agreement with experimental permea-
tion measurements, demonstrating that these calcula-
tions provide accurate in silico kinetic rates for these 
important dynamical processes. Additionally, we ana-
lyzed the free energy surfaces corresponding to the ori-
entations of the seven drugs molecules while crossing the 
membrane by determining MSMs on a two dimensional 
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 (2D) surface using DHAM, describing in detail the orien-
tation for three of them. This provides key insights into 
the drug permeation pathways and offers guidance for 
the design of molecules with required kinetic permeation 
properties. 
 
II. METHOD 
a. Markov State Modelling 
An MSM consists of a set of memoryless conditional 
probabilities between user-defined discrete states (in our 
implementation along a finely discretized chosen reac-
tion coordinate z), such that the value of ( , | ,0)P j t i  is the 
probability that the system is in state j at time t given that 
it was in state i initially. These conditional probabilities 
are typically calculated by determining the transition 
count matrix 
jiC , which contains the count numbers of 
the observed transitions from state i to j. The time pa-
rameter t is called the lagtime and must be chosen suffi-
ciently large such that the Chapman-Kolmogorov test32 is 
satisfied (i.e. that the relaxation timescales, τ  of the sys-
tem are insensitive to changes in the lagtime).  
To produce an MSM from enhanced sampling simulations 
in practice, we use a reaction coordinate of interest that 
was also employed to bias the MD simulation data. In the 
context of membrane permeation, it is desired to com-
pute the kinetic rates with which the drug undergoes 
three important processes (see Fig. 1): the rate at which 
it enters into (kin), crosses (kflip), and exits (kout) from the 
membrane. The corresponding reaction coordinate is the 
distance between the center of mass (COM) of the ligand 
and the center of the lipid membrane (z-coordinate as 
shown in Fig. 1) was used. Unlike in typical MSM models 
consisting of only metastable states, here we discretized 
this coordinate into bins, where the number of bins is 
chosen sufficiently large to give a finely discretized coor-
dinate but not so large as to give an under-sampling of 
transitions between bins. 
Once the bins have been determined, we count the num-
ber of observed transitions ( ( )kjiC t ) between each pair 
of bins i and j in simulation k at the chosen lagtime t, as 
well as the number of times each bin is occupied  
( ( )k ki ji
j
n C t= ∑ ) during each simulation k. These 
values then provide the necessary conditional probabili-
ties ( ) ( , | ,0)jiM t P j t i= . In the simplest unbiased case 
not enforcing detailed balance strictly, the maximum like-
lihood estimates are given by:   
  
 
( )
( )
k
ji
k
ji k
i
k
C t
M t
n
=
∑
∑
  (1) 
For biased simulations where a biasing energy of 
k
iu  is 
applied to state i during simulation k, we employed the 
DHAM30 to compute the unbiased MSM from the biased 
data as given by: 
 
( )
( )
exp( ( ) / 2 )
k
ji
k
ji k k k
i j i b
k
C t
M t
n u u k T
=
− −
∑
∑
  (2) 
Eq. (2) reduces to the unbiased equation when the bias-
ing potentials are set to zero. Once an MSM has been con-
structed from simulation data, one is typically interested 
in determining the free energy profile as well as the ki-
netic information (relaxation times and mean first pas-
sage times). These quantities can be computed directly 
from the eigenvalues nλ  and eigenfunctions nψ  of the 
transition matrix. All the eigenvalues of the transition 
matrix with detailed balance fall between 1 and 0 and can 
be arranged in decreasing order: 
  
 1 21 ... 0nλ λ λ= > ≥ ≥ >   (3) 
  
The largest eigenvalue (equal to 1) gives the equilibrium 
populations of the states of the system (useful to find the 
free energy) while the second largest eigenvalue can be 
used to determine the timescale of the slowest relaxation 
process in the system via: 
  
 2
2ln( )
t
τ
λ
−
=   (4) 
  
The kinetic rates are computed by coarse graining our 
discretized states and corresponding free energy profile 
into four regions: the outer water, outer membrane, inner 
membrane and inner water regions (Fig. 1), using the 
Robust Perron Cluster Analysis (PCCA+) method33 follow-
ing Dickson  et al.29 Once the clusters have been specified, 
we calculate the rates (kin, kflip and kout) from the Markov 
matrix as the inverse of the mean first passage times 
(MFPT)34 between the regions. 
The log Perm permeability values are typically calculated 
using Eq. (5): 
 Perm
3
slow
k r
=   (5) 
 
Where  slowk  is defined to be the rate of the slowest pro-
cess in the system, i.e. the process which is most signifi-
cant in describing the decay of the populations to equilib-
rium and r is the radius of the liposome (100 nm). It 
should also be noted that in this context we use a base 
ten logarithm as is typically used when analyzing mem-
brane permeability values. Typically, for membrane 
crossings, it is estimated by setting up a system of equa-
tions using the three rates (kin, kflip and kout) as inputs, 
solving these equations in a kinetic network model and 
fitting the time dependent populations to a bi-
exponential curve. Here we propose a simpler and more 
Page 3 of 12
ACS Paragon Plus Environment
The Journal of Physical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 direct approach to calculate the overall slowest relaxation 
time directly from the original Markov model and obtain 
a corresponding rate for slowk . We compared and demon-
strated that this simple approach is highly accurate and 
results in a similar slowk  estimate as the traditional ap-
proach. 
Recently a number of advances of DHAM have been 
proposed where detailed balance is included35-37. We 
found that enforcing detailed balance did not lead to any 
observable changes in many US test cases we studied 
(data not shown), therefore here we used the simplest 
original DHAM approach via Eq. (2)30, 35. 
 
b. Simulation Details 
Compounds were modelled with the parm@Frosst force 
field, a small molecule force field that extends AMBER 
ff99SB,38 and uses conformationally averaged AM1-BCC 
charges; lipids were modelled using the AMBER Lipid14 
force field and water using TIP3P model. MD simulations 
were run with AMBER16 and PMEMD CUDA on GPU 
cards39. 
The starting structures for the US simulations are ob-
tained by placing each ligand at the center of a POPC bi-
layer surrounded by water molecules (72 POPC and  
60 waters per lipid)40. Three-dimensional periodic 
boundary conditions with the usual minimum image con-
vention were employed. Energy minimization is per-
formed by using the steepest descent method for 5000 
steps and using the conjugate gradient method for fur-
ther 5000 steps. 
The system was then heated from 0 K to 100 K using 
Langevin dynamics within a 5 ps constant volume run, 
with restraints on the drug molecule and lipids using a 
force constant of 10 kcal mol-1 Å-2. Subsequently, the vol-
ume was allowed to change freely increasing the temper-
ature to 303 K. The Langevin collision frequency was  
ɣ=1 ps-1; and anisotropic Berendsen control of the pres-
sure around 1 atm was applied by coupling the periodic 
box with a time constant of 2 ps for 100 ps. 
The equilibration was completed after an additional 5 ns 
with the pressure relaxation time reduced to 1 ps in NPT, 
removing the restrain on lipids. The SHAKE algorithm41 
was used to constrain the bonds involving hydrogen and 
a time step of 2 fs was used. 
Using a pulling rate of 1 Å/ns the drugs were then pulled 
out from the center of the system to outside the mem-
brane, for a total of 40 Å (force constant of  
1.1 kcal mol-1 Å-2), in the NPT ensemble with semi-
isotropic pressure scaling. During the simulations, a 
snapshot was saved every 1 Å, from the center z=0 Å to 
z=40 Å generating 40 windows. The results were calcu-
lated for one bilayer leaflet and it was assumed that the 
second half behaves in the same way. This was achieved 
by reflecting the data along the z axis and adding 39 
(Figs. S1-S8) or 40 windows (Fig. 5), depending on 
whether or not the window at z=0 Å was reflected as 
well. Each US window was run for 20 ns to allow equili-
bration followed by additional 80 ns of production run 
using an US force constant of  
2.5 kcal mol-1 Å-2. Configurations were recorded every  
10 ps. 
 
c. 2D-DHAM 
Analogously to the 1D case, we constructed a finely dis-
cretized 2D grid to determine the MSMs along two reac-
tion coordinates for the seven drugs. 
Specifically for domperidone, loperamide and labetalol, 
we analyzed the rotational movement of the drug during 
its passage across the membrane.  
As our first reaction coordinate we used the same z coor-
dinate as previously (distance from ligand COM to mem-
brane center). For our second coordinate, we use the pro-
jection of the molecular orientation vector onto the z co-
ordinate Δz, as a measurement of the orientation of the 
ligand with respect to the membrane for two selected 
regions of the drug molecule along its length. Δz is equiv-
alent to the molecular length scaled by the cosine of the 
angle between the z axes of the membrane and the mo-
lecular vector defined by the two ends of the ligand (Fig. 
3). This means that when the ligand is oriented parallel to 
the membrane Δz will be around 0 Å as both ends are 
equidistant from the membrane, whereas when it is ori-
ented perpendicular then Δz will be equal the end-to-end 
length of the ligand (around -10 to 10 Å). The extremities 
of the ligand can be the COM of distal functional groups 
(e.g. benzene) or single atoms, as shown in Fig. 3 for the 
molecules considered here. 
This 2D-DHAM analysis and the 2D free energy surfaces 
are used to find correlations between the rotation of the 
ligand and its position across the membrane, showing 
Figure 3. Definition of the Δz coordinate used in our 2D 
DHAM analysis. The values are obtained by projecting the 
vector along the drug molecules’ length, as shown by the red 
arrows onto the z axis. The vector describing the molecular 
length joins the COM of the circled atoms as shown for 
Domperidone (a), Labetalol (b) and Loperamide (c). 
Page 4 of 12
ACS Paragon Plus Environment
The Journal of Physical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 how the orientations of the ligand affect the free energies 
while crossing the membrane.  
 
III. RESULTS AND DISCUSSION 
a. MSM analysis of US simulations 
Using the Markov modelling methods and US simulation 
trajectories, the relaxation time, 2τ , was calculated by 
constructing MSMs at a range of lagtimes up to 300 ps 
with 1000 bins as shown in Fig. 4. Using a recently de-
rived method for calculating the limiting relaxation time 
of an MSM42, we determined the long lagtime limit of the 
relaxation time for each drug as shown by the dashed 
lines in  
Fig. 4. The relaxation times can be seen to level off in the 
region of lagtimes greater than 100 ps. In the analysis 
that follows, we chose to use a lagtime of 200 ps, as it is 
sufficiently large for 2τ  to be insensitive to the precise 
choice of the lagtime. When calculating the MSMs with 
bin numbers of 600, 800, and 1000, at our chosen lagtime 
of  
200 ps, there is almost no change in the obtained free 
energy profiles (Figs. S1-S7). We used 1000 bins for all 
subsequent analysis. 
 
 
Figure 4. Relaxation time vs lagtime of the seven drugs (Fig. 
2). The dashed lines represent the long lagtime limit of the 
relaxation time obtained by a least squares fitting to the 
relaxation times in the range of 1 ps to 300 ps. 
Following this initial choice of parameters, seven Markov 
models were constructed with 1000 bins and a lagtime of 
200 ps (100,000 simulation steps). This allows us to 
compute the free energy profiles for each drug and draw 
comparison with the profiles obtained in the unbiased 
simulations using WHAM (Fig. 5). Error bars were de-
termined by dividing the data into two equal sections, 
determining the profiles independently and calculating 
the variance. 
All our free energy profiles show the same trend as the 
one calculated by Dickson et al.29 (dotted lines in Fig. 5) 
for the combined unbiased and biased MD data and in-
deed all the WHAM predictions fall within the margin of 
error for the DHAM results. While the PMF changes de-
pending on whether the US window at z=0 Å was reflect-
ed or not (Figs. 5 and S8), the log Perm data is essentially 
unchanged. The asymmetry observed in the not fully re-
flected PMF profiles also suggests that longer simulations 
might be needed to reduce the error at this transition 
region. At the same time, we used a fraction of the data 
required for the unbiased simulations. We obtained the 
kinetics profile using the US data by Dickson et al29  with 
a total simulation time of  
3.2 μs for each drug, whereas in the work done by Dick-
son et al.,29 the calculation of the kinetic profile required 
multiple unbiased simulations, with a total simulation 
time of 12.5 μs per drug. By analyzing the US data with 
DHAM, we are able to reduce the total time by at least 
75% over using unbiased data. 
 
b. Ordering drugs according to their permeability 
To determine the relative permeability, it is required to 
compare the rate of the slowest occurring process, slowk  
corresponding to the crossing of the free energy barrier 
at the center of the membrane amongst the different drug 
molecules. Here we considered several ways to estimate 
the relative ordering (Table S1). Firstly, we can use the 
overall relaxation time corresponding to the second ei-
genvalue of the MSM constructed for each drug using Eq. 
(4). Secondly, we can make use of the free energy profile 
alone, and compare the height of the free energy barrier 
across the different drugs, using an Arrhenius relation-
ship: 
 
‡
B
G
k T
slowk Ae
−∆
=   (6) 
Using the relaxation time obtained from the MSM in con-
junction with the 
‡G∆  calculated from the populations, 
we can determine the Arrhenius prefactor. We obtained 
similar prefactors for all the drugs (Table S1), with an 
average value of 9.72 ± 5.76 e+07 s-1, four orders of mag-
nitude bigger than the typical value of B
k T
A
h
=  consid-
ering a transmission coefficient close to 1. 
Thirdly, as the barrier corresponds to the flipping pro-
cess, we can use the rate constants determined by mean 
first passage times, assuming slow flipk k≈  . 
These three methods are each computationally simple to 
implement compared with alternative methods in the 
field of simulating a kinetic system from the calculated 
rates and performing a bi-exponential fit to the resultant 
time-dependent probabilities.  
The biased and unbiased calculated log Perm values cor-
relate very well with the experimental data (Fig. 6). The 
US simulation data displays similar R2 values from the 
linear fit as the original kinetic data.  
 
The log Perm values from the combination of unbiased 
and biased potential of mean force (PMF) data with the 
discrete transition based reweighting analysis method 
(dTRAM) of Dickson et al.29 mostly lie above the experi-
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 mental values predicting slightly faster permeation while 
the biased values are almost all below the line. This slow 
timescale might be because our model was calculated at a 
larger lagtime. Increasing the lagtime will increase the 
relaxation time and in turn decrease the value of the rate 
of the slowest process, resulting in a smaller permeability 
value. We expect that the most accurate simulation-based 
rate estimates are calculated from all data (biased and 
unbiased) using longer lagtimes.  
 
Importantly, the process of ordering drugs according to 
their permeability is insensitive to the precise choice of 
lagtime. This can also be seen from Fig. 4, where the or-
dering of the lines does not change as a function of the 
lagtime, predicting the same ordering in a lagtime inde-
pendent manner. This demonstrates that equivalently 
high correlations can be found between the experimental 
and biased data as with the unbiased data. Furthermore, 
using the simple approach of the relaxation time of the 
full Markov state model is an appropriate way to order 
the permeability of the drugs.  
 
Figure 6. The log Perm values determined by the biased and 
unbiased simulations are compared with the experimental 
values14, 29. The correlation in between the data sets is com-
parably high for both the biased and unbiased simulations 
(both have p-values of well below the 5% required to be 
statistically significant). 
By analyzing various kinetic quantities as predictors of 
the ordering of the drugs by permeability, we found that 
in general, any sensible choice of kinetic quantity which 
is closely related to the barrier crossing process will 
serve as an accurate indicator of drug ordering as shown 
in  
Table S1.  
 The MSM relaxation times correlate very well with the 
calculated free energy barriers (Fig. S9). The correspond-
ing permeation obtained from the free energy barrier 
heights using an Arrhenius rate expression with a con-
stant prefactor of kBT/h does not match the experimental 
log Perm values as closely as the MSM relaxation times, 
but because the R2 calculations are invariant under linear 
transformations, the free energy barrier can also be used 
to calculate log Perm values accurately. However, if the 
permeation is investigated using different membrane 
compositions, the Arrhenius prefactor may vary, and a 
kinetic comparison using MSMs might become necessary. 
 
c. 2D-DHAM 
Using the 2D-DHAM analysis we calculated the 2D free 
energy surface of all seven drugs (Figs. S10-S16). Here we 
illustrate the results on three of them: domperidone, 
loperamide and labetalol, focusing on the rotation of the 
molecules while crossing the membrane.  
We also verified that the free energy barriers from the 
2D-DHAM analysis agree well with 1D-DHAM results.  
Figure 5. The free energy profiles calculated with DHAM from 
US simulations (solid lines) and WHAM using unbiased MD 
data (dashed lines). Errors are represented by shaded area for 
US data. 
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Figure 7: 2D free energy surfaces of (a) Domperidone, (b) 
Labetalol and (c) Loperamide along the absolute z position 
of the ligand, and the Δz coordinate for each molecule 
(schematic representation of the molecule orientation is also 
shown). The preferred paths for membrane crossing are 
shown as a function of the molecule orientation (red dotted 
lines). 
Domperidone, Fig. 7(a), due to its polar characteristic, 
has a specific orientation inside the membrane. In the 
surrounding aqueous region the molecule is free to rotate 
its z position between -40 and -25 Å. Once near the 
membrane, domperidone has a preferential orientation 
parallel to the surface of the membrane. Between the 
inter lipid region and the polar head (0 Å  < z < 20 Å) of 
the membrane it orientates perpendicular to the z coor-
dinate showing a particular preference where the struc-
ture is parallel to the membrane surface.  
 
Due to its dipole moment, in between the two-
phospholipidic layers, domperidone switches position 
preferring a parallel orientation with its more polar end 
pointing towards the water along z coordinate. This phe-
nomenon is known as solute hopping43. 
The second compound, labetalol, Fig. 7(b) has an even 
stronger polar side, due to the presence of both hydroxyl 
groups and an amide group. On the other end, the mole-
cule has a hydrophobic side, showing an overall "lipid-
like" structure. When the drug is near the polar head of 
the membrane, it keeps its polar region close to the polar 
side of the membrane. Once at the intermembrane layer, 
it has a rapid interchange of orientation, keeping always 
its polar region close to the polar region of the membrane 
closest to bulk water. 
Loperamide, Fig. 7(c), is the most hydrophobic of the 
three drugs, it prefers a specific orientation only when 
entering the membrane, with its hydroxylic group facing 
the membrane headgroups. Once entered, it tends to have 
relatively high rotational freedom.  
As quantitatively assessed by 2D free energy surfaces as a 
function of the z and Δz coordinates, depending on the 
polarity and symmetry of the molecule, once inside the 
membrane, molecules have specific preferential orienta-
tions during the passage across the membrane. Several 
works have already been done to analyze the orientation 
of the ligands while crossing the membrane44-47, and our 
results and general trends from the 2D-DHAM analysis 
agree with these previous works. Polar molecules keep 
their polar region facing towards the polar heads of the 
membrane, while more lipophilic compounds have a 
higher rotational freedom. Furthermore, polarity and 
charge distribution also determines the orientation of 
entry and the corresponding free energy pathways into 
the lipid membrane. 
 
IV. CONCLUSION 
 
We demonstrate that by performing a series of biased 
simulations of a drug molecule near a lipid membrane, 
highly accurate equilibrium and kinetic information can 
be determined by constructing an MSM using DHAM. This 
gives results which agree closely with experiment and 
achieve similar levels of accuracy as those attained by 
much longer unbiased MD simulations.  
 
Furthermore, we present a simpler method for calculat-
ing permeability coefficients from MD simulation data by 
calculating the relaxation time directly from the MSMs. 
We also find that if the goal is to order the drugs accord-
ing to permeability, then most kinetic quantities correlate 
with the free energy barrier to cross the membrane, indi-
cating that linear transformations would give an excellent 
approximation to the experimental log Perm value. While 
this is very promising to order drugs in the same mem-
brane environment, possibly such correlation with the 
barrier height no longer holds across different mem-
brane/aqueous environments. We found that the prefac-
tor in the Eyring equation differed by about four orders 
of magnitude from kBT/h. This could potentially be due to 
the fact that the diffusion coefficients are very different 
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 inside the membrane that has a very different dielectric 
constant than water, or could be due to other factors, in-
cluding the choice of the reaction coordinates affecting 
the transmission coefficient.  
 
Finally, we constructed 2D free energy surfaces and cor-
responding MSMs for three of our drug molecules and 
interpret the crossing mechanisms in terms of the physi-
cal processes occurring during the simulations. The mo-
lecular properties, i.e., charge distribution and lipophilici-
ty of the solute determine specific rotational preferences 
and pathways during the membrane entrance and cross-
ing processes. 
 
Our results demonstrate that DHAM is capable to provide 
accurate molecular kinetic information from purely bi-
ased simulations. As the range of systems with biased 
simulations is very flexible, we plan to apply this method 
in multiple applications. We can determine unbinding 
rates in molecular systems such as in host guest com-
plexes, e.g., the competitive binding of ethanol and meth-
anol with cucurbiturils in nano-aggregates of Au nano-
particles in aqueous environment48, or for catalytic rates 
of enzyme catalyzed chemical reactions, such as e.g., the 
reaction mechanism of lipoxigenases49. Future work will 
be addressed to larger ligand permeability data sets, the 
kinetic prediction of ligand-protein unbinding and other 
important relevant kinetic processes. 
 
Supporting Information 
PMF profiles for the 7 studied drugs, permeability coeffi-
cient data, 2D free energy profiles. 
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